Table of Content

1 Hip Osteoarthritis Pain Medicine Market Overview
1.1 Product Overview and Scope of Hip Osteoarthritis Pain Medicine
1.2 Hip Osteoarthritis Pain Medicine Segment by Type
1.2.1 Global Hip Osteoarthritis Pain Medicine Market Value Comparison by Type (2024-2034)
1.2.2 Oral
1.2.3 Injection
1.2.4 External
1.3 Hip Osteoarthritis Pain Medicine Segment by Application
1.3.1 Global Hip Osteoarthritis Pain Medicine Market Value by Application: (2024-2034)
1.3.2 Medical Care
1.3.3 Personal Care
1.4 Global Hip Osteoarthritis Pain Medicine Market Size Estimates and Forecasts
1.4.1 Global Hip Osteoarthritis Pain Medicine Revenue 2018-2034
1.4.2 Global Hip Osteoarthritis Pain Medicine Sales 2018-2034
1.4.3 Global Hip Osteoarthritis Pain Medicine Market Average Price (2018-2034)
1.5 Assumptions and Limitations
2 Hip Osteoarthritis Pain Medicine Market Competition by Manufacturers
2.1 Global Hip Osteoarthritis Pain Medicine Sales Market Share by Manufacturers (2018-2023)
2.2 Global Hip Osteoarthritis Pain Medicine Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Hip Osteoarthritis Pain Medicine Average Price by Manufacturers (2018-2023)
2.4 Global Hip Osteoarthritis Pain Medicine Industry Ranking 2021 VS 2024 VS 2023
2.5 Global Key Manufacturers of Hip Osteoarthritis Pain Medicine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Hip Osteoarthritis Pain Medicine, Product Type & Application
2.7 Hip Osteoarthritis Pain Medicine Market Competitive Situation and Trends
2.7.1 Hip Osteoarthritis Pain Medicine Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Hip Osteoarthritis Pain Medicine Players Market Share by Revenue
2.7.3 Global Hip Osteoarthritis Pain Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Hip Osteoarthritis Pain Medicine Retrospective Market Scenario by Region
3.1 Global Hip Osteoarthritis Pain Medicine Market Size by Region: 2018 Versus 2024 Versus 2034
3.2 Global Hip Osteoarthritis Pain Medicine Global Hip Osteoarthritis Pain Medicine Sales by Region: 2018-2034
3.2.1 Global Hip Osteoarthritis Pain Medicine Sales by Region: 2018-2023
3.2.2 Global Hip Osteoarthritis Pain Medicine Sales by Region: 2024-2034
3.3 Global Hip Osteoarthritis Pain Medicine Global Hip Osteoarthritis Pain Medicine Revenue by Region: 2018-2034
3.3.1 Global Hip Osteoarthritis Pain Medicine Revenue by Region: 2018-2023
3.3.2 Global Hip Osteoarthritis Pain Medicine Revenue by Region: 2024-2034
3.4 North America Hip Osteoarthritis Pain Medicine Market Facts & Figures by Country
3.4.1 North America Hip Osteoarthritis Pain Medicine Market Size by Country: 2018 VS 2024 VS 2034
3.4.2 North America Hip Osteoarthritis Pain Medicine Sales by Country (2018-2034)
3.4.3 North America Hip Osteoarthritis Pain Medicine Revenue by Country (2018-2034)
3.4.4 U.S.
3.4.5 Canada
3.5 Europe Hip Osteoarthritis Pain Medicine Market Facts & Figures by Country
3.5.1 Europe Hip Osteoarthritis Pain Medicine Market Size by Country: 2018 VS 2024 VS 2034
3.5.2 Europe Hip Osteoarthritis Pain Medicine Sales by Country (2018-2034)
3.5.3 Europe Hip Osteoarthritis Pain Medicine Revenue by Country (2018-2034)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Hip Osteoarthritis Pain Medicine Market Facts & Figures by Country
3.6.1 Asia Pacific Hip Osteoarthritis Pain Medicine Market Size by Country: 2018 VS 2024 VS 2034
3.6.2 Asia Pacific Hip Osteoarthritis Pain Medicine Sales by Country (2018-2034)
3.6.3 Asia Pacific Hip Osteoarthritis Pain Medicine Revenue by Country (2018-2034)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.6.13 Philippines
3.7 Latin America Hip Osteoarthritis Pain Medicine Market Facts & Figures by Country
3.7.1 Latin America Hip Osteoarthritis Pain Medicine Market Size by Country: 2018 VS 2024 VS 2034
3.7.2 Latin America Hip Osteoarthritis Pain Medicine Sales by Country (2018-2034)
3.7.3 Latin America Hip Osteoarthritis Pain Medicine Revenue by Country (2018-2034)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Hip Osteoarthritis Pain Medicine Market Facts & Figures by Country
3.8.1 Middle East and Africa Hip Osteoarthritis Pain Medicine Market Size by Country: 2018 VS 2024 VS 2034
3.8.2 Middle East and Africa Hip Osteoarthritis Pain Medicine Sales by Country (2018-2034)
3.8.3 Middle East and Africa Hip Osteoarthritis Pain Medicine Revenue by Country (2018-2034)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Hip Osteoarthritis Pain Medicine Sales by Type (2018-2034)
4.1.1 Global Hip Osteoarthritis Pain Medicine Sales by Type (2018-2023)
4.1.2 Global Hip Osteoarthritis Pain Medicine Sales by Type (2024-2034)
4.1.3 Global Hip Osteoarthritis Pain Medicine Sales Market Share by Type (2018-2034)
4.2 Global Hip Osteoarthritis Pain Medicine Revenue by Type (2018-2034)
4.2.1 Global Hip Osteoarthritis Pain Medicine Revenue by Type (2018-2023)
4.2.2 Global Hip Osteoarthritis Pain Medicine Revenue by Type (2024-2034)
4.2.3 Global Hip Osteoarthritis Pain Medicine Revenue Market Share by Type (2018-2034)
4.3 Global Hip Osteoarthritis Pain Medicine Price by Type (2018-2034)
5 Segment by Application
5.1 Global Hip Osteoarthritis Pain Medicine Sales by Application (2018-2034)
5.1.1 Global Hip Osteoarthritis Pain Medicine Sales by Application (2018-2023)
5.1.2 Global Hip Osteoarthritis Pain Medicine Sales by Application (2024-2034)
5.1.3 Global Hip Osteoarthritis Pain Medicine Sales Market Share by Application (2018-2034)
5.2 Global Hip Osteoarthritis Pain Medicine Revenue by Application (2018-2034)
5.2.1 Global Hip Osteoarthritis Pain Medicine Revenue by Application (2018-2023)
5.2.2 Global Hip Osteoarthritis Pain Medicine Revenue by Application (2024-2034)
5.2.3 Global Hip Osteoarthritis Pain Medicine Revenue Market Share by Application (2018-2034)
5.3 Global Hip Osteoarthritis Pain Medicine Price by Application (2018-2034)
6 Key Companies Profiled
6.1 Pfizer
6.1.1 Pfizer Corporation Information
6.1.2 Pfizer Description and Business Overview
6.1.3 Pfizer Hip Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2018-2023)
6.1.4 Pfizer Hip Osteoarthritis Pain Medicine Product Portfolio
6.1.5 Pfizer Recent Developments/Updates
6.2 Johnson and Johnson
6.2.1 Johnson and Johnson Corporation Information
6.2.2 Johnson and Johnson Description and Business Overview
6.2.3 Johnson and Johnson Hip Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Johnson and Johnson Hip Osteoarthritis Pain Medicine Product Portfolio
6.2.5 Johnson and Johnson Recent Developments/Updates
6.3 GlaxoSmithKline
6.3.1 GlaxoSmithKline Corporation Information
6.3.2 GlaxoSmithKline Description and Business Overview
6.3.3 GlaxoSmithKline Hip Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2018-2023)
6.3.4 GlaxoSmithKline Hip Osteoarthritis Pain Medicine Product Portfolio
6.3.5 GlaxoSmithKline Recent Developments/Updates
6.4 Bayer
6.4.1 Bayer Corporation Information
6.4.2 Bayer Description and Business Overview
6.4.3 Bayer Hip Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Bayer Hip Osteoarthritis Pain Medicine Product Portfolio
6.4.5 Bayer Recent Developments/Updates
6.5 Eli Lilly
6.5.1 Eli Lilly Corporation Information
6.5.2 Eli Lilly Description and Business Overview
6.5.3 Eli Lilly Hip Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Eli Lilly Hip Osteoarthritis Pain Medicine Product Portfolio
6.5.5 Eli Lilly Recent Developments/Updates
6.6 Novartis
6.6.1 Novartis Corporation Information
6.6.2 Novartis Description and Business Overview
6.6.3 Novartis Hip Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2018-2023)
6.6.4 Novartis Hip Osteoarthritis Pain Medicine Product Portfolio
6.6.5 Novartis Recent Developments/Updates
6.7 Sanofi
6.6.1 Sanofi Corporation Information
6.6.2 Sanofi Description and Business Overview
6.6.3 Sanofi Hip Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Sanofi Hip Osteoarthritis Pain Medicine Product Portfolio
6.7.5 Sanofi Recent Developments/Updates
6.8 Horizon Pharma
6.8.1 Horizon Pharma Corporation Information
6.8.2 Horizon Pharma Description and Business Overview
6.8.3 Horizon Pharma Hip Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Horizon Pharma Hip Osteoarthritis Pain Medicine Product Portfolio
6.8.5 Horizon Pharma Recent Developments/Updates
6.9 Abbott
6.9.1 Abbott Corporation Information
6.9.2 Abbott Description and Business Overview
6.9.3 Abbott Hip Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Abbott Hip Osteoarthritis Pain Medicine Product Portfolio
6.9.5 Abbott Recent Developments/Updates
6.10 Mylan
6.10.1 Mylan Corporation Information
6.10.2 Mylan Description and Business Overview
6.10.3 Mylan Hip Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Mylan Hip Osteoarthritis Pain Medicine Product Portfolio
6.10.5 Mylan Recent Developments/Updates
6.11 Daiichi Sankyo
6.11.1 Daiichi Sankyo Corporation Information
6.11.2 Daiichi Sankyo Hip Osteoarthritis Pain Medicine Description and Business Overview
6.11.3 Daiichi Sankyo Hip Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Daiichi Sankyo Hip Osteoarthritis Pain Medicine Product Portfolio
6.11.5 Daiichi Sankyo Recent Developments/Updates
6.12 TEVA
6.12.1 TEVA Corporation Information
6.12.2 TEVA Hip Osteoarthritis Pain Medicine Description and Business Overview
6.12.3 TEVA Hip Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2018-2023)
6.12.4 TEVA Hip Osteoarthritis Pain Medicine Product Portfolio
6.12.5 TEVA Recent Developments/Updates
6.13 Almatica Pharma
6.13.1 Almatica Pharma Corporation Information
6.13.2 Almatica Pharma Hip Osteoarthritis Pain Medicine Description and Business Overview
6.13.3 Almatica Pharma Hip Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Almatica Pharma Hip Osteoarthritis Pain Medicine Product Portfolio
6.13.5 Almatica Pharma Recent Developments/Updates
6.14 Astellas Pharma
6.14.1 Astellas Pharma Corporation Information
6.14.2 Astellas Pharma Hip Osteoarthritis Pain Medicine Description and Business Overview
6.14.3 Astellas Pharma Hip Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2018-2023)
6.14.4 Astellas Pharma Hip Osteoarthritis Pain Medicine Product Portfolio
6.14.5 Astellas Pharma Recent Developments/Updates
6.15 Tide Pharmaceutical
6.15.1 Tide Pharmaceutical Corporation Information
6.15.2 Tide Pharmaceutical Hip Osteoarthritis Pain Medicine Description and Business Overview
6.15.3 Tide Pharmaceutical Hip Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2018-2023)
6.15.4 Tide Pharmaceutical Hip Osteoarthritis Pain Medicine Product Portfolio
6.15.5 Tide Pharmaceutical Recent Developments/Updates
6.16 Iroko Pharmaceuticals
6.16.1 Iroko Pharmaceuticals Corporation Information
6.16.2 Iroko Pharmaceuticals Hip Osteoarthritis Pain Medicine Description and Business Overview
6.16.3 Iroko Pharmaceuticals Hip Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2018-2023)
6.16.4 Iroko Pharmaceuticals Hip Osteoarthritis Pain Medicine Product Portfolio
6.16.5 Iroko Pharmaceuticals Recent Developments/Updates
6.17 Hengrui Pharmaceutical
6.17.1 Hengrui Pharmaceutical Corporation Information
6.17.2 Hengrui Pharmaceutical Hip Osteoarthritis Pain Medicine Description and Business Overview
6.17.3 Hengrui Pharmaceutical Hip Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2018-2023)
6.17.4 Hengrui Pharmaceutical Hip Osteoarthritis Pain Medicine Product Portfolio
6.17.5 Hengrui Pharmaceutical Recent Developments/Updates
6.18 Abiogen Pharma
6.18.1 Abiogen Pharma Corporation Information
6.18.2 Abiogen Pharma Hip Osteoarthritis Pain Medicine Description and Business Overview
6.18.3 Abiogen Pharma Hip Osteoarthritis Pain Medicine Sales, Revenue and Gross Margin (2018-2023)
6.18.4 Abiogen Pharma Hip Osteoarthritis Pain Medicine Product Portfolio
6.18.5 Abiogen Pharma Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Hip Osteoarthritis Pain Medicine Industry Chain Analysis
7.2 Hip Osteoarthritis Pain Medicine Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Hip Osteoarthritis Pain Medicine Production Mode & Process
7.4 Hip Osteoarthritis Pain Medicine Sales and Marketing
7.4.1 Hip Osteoarthritis Pain Medicine Sales Channels
7.4.2 Hip Osteoarthritis Pain Medicine Distributors
7.5 Hip Osteoarthritis Pain Medicine Customers
8 Hip Osteoarthritis Pain Medicine Market Dynamics
8.1 Hip Osteoarthritis Pain Medicine Industry Trends
8.2 Hip Osteoarthritis Pain Medicine Market Drivers
8.3 Hip Osteoarthritis Pain Medicine Market Challenges
8.4 Hip Osteoarthritis Pain Medicine Market Restraints
9 Research Finding and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer

List of Figure

List of Tables
Table 1. Global Hip Osteoarthritis Pain Medicine Market Value Comparison by Type (2024-2034) & (US$ Million)
Table 2. Global Hip Osteoarthritis Pain Medicine Market Value Comparison by Application (2024-2034) & (US$ Million)
Table 3. Global Hip Osteoarthritis Pain Medicine Market Competitive Situation by Manufacturers in 2024
Table 4. Global Hip Osteoarthritis Pain Medicine Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Hip Osteoarthritis Pain Medicine Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Hip Osteoarthritis Pain Medicine Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Hip Osteoarthritis Pain Medicine Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Hip Osteoarthritis Pain Medicine Average Price (USD/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Hip Osteoarthritis Pain Medicine, Industry Ranking, 2021 VS 2024 VS 2023
Table 10. Global Key Manufacturers of Hip Osteoarthritis Pain Medicine, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Hip Osteoarthritis Pain Medicine, Product Type & Application
Table 12. Global Key Manufacturers of Hip Osteoarthritis Pain Medicine, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Hip Osteoarthritis Pain Medicine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hip Osteoarthritis Pain Medicine as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Hip Osteoarthritis Pain Medicine Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Table 17. Global Hip Osteoarthritis Pain Medicine Sales by Region (2018-2023) & (K Units)
Table 18. Global Hip Osteoarthritis Pain Medicine Sales Market Share by Region (2018-2023)
Table 19. Global Hip Osteoarthritis Pain Medicine Sales by Region (2024-2034) & (K Units)
Table 20. Global Hip Osteoarthritis Pain Medicine Sales Market Share by Region (2024-2034)
Table 21. Global Hip Osteoarthritis Pain Medicine Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Hip Osteoarthritis Pain Medicine Revenue Market Share by Region (2018-2023)
Table 23. Global Hip Osteoarthritis Pain Medicine Revenue by Region (2024-2034) & (US$ Million)
Table 24. Global Hip Osteoarthritis Pain Medicine Revenue Market Share by Region (2024-2034)
Table 25. North America Hip Osteoarthritis Pain Medicine Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 26. North America Hip Osteoarthritis Pain Medicine Sales by Country (2018-2023) & (K Units)
Table 27. North America Hip Osteoarthritis Pain Medicine Sales by Country (2024-2034) & (K Units)
Table 28. North America Hip Osteoarthritis Pain Medicine Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Hip Osteoarthritis Pain Medicine Revenue by Country (2024-2034) & (US$ Million)
Table 30. Europe Hip Osteoarthritis Pain Medicine Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 31. Europe Hip Osteoarthritis Pain Medicine Sales by Country (2018-2023) & (K Units)
Table 32. Europe Hip Osteoarthritis Pain Medicine Sales by Country (2024-2034) & (K Units)
Table 33. Europe Hip Osteoarthritis Pain Medicine Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Hip Osteoarthritis Pain Medicine Revenue by Country (2024-2034) & (US$ Million)
Table 35. Asia Pacific Hip Osteoarthritis Pain Medicine Revenue by Region: 2018 VS 2024 VS 2034 (US$ Million)
Table 36. Asia Pacific Hip Osteoarthritis Pain Medicine Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Hip Osteoarthritis Pain Medicine Sales by Region (2024-2034) & (K Units)
Table 38. Asia Pacific Hip Osteoarthritis Pain Medicine Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Hip Osteoarthritis Pain Medicine Revenue by Region (2024-2034) & (US$ Million)
Table 40. Latin America Hip Osteoarthritis Pain Medicine Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 41. Latin America Hip Osteoarthritis Pain Medicine Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Hip Osteoarthritis Pain Medicine Sales by Country (2024-2034) & (K Units)
Table 43. Latin America Hip Osteoarthritis Pain Medicine Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Hip Osteoarthritis Pain Medicine Revenue by Country (2024-2034) & (US$ Million)
Table 45. Middle East & Africa Hip Osteoarthritis Pain Medicine Revenue by Country: 2018 VS 2024 VS 2034 (US$ Million)
Table 46. Middle East & Africa Hip Osteoarthritis Pain Medicine Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Hip Osteoarthritis Pain Medicine Sales by Country (2024-2034) & (K Units)
Table 48. Middle East & Africa Hip Osteoarthritis Pain Medicine Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Hip Osteoarthritis Pain Medicine Revenue by Country (2024-2034) & (US$ Million)
Table 50. Global Hip Osteoarthritis Pain Medicine Sales (K Units) by Type (2018-2023)
Table 51. Global Hip Osteoarthritis Pain Medicine Sales (K Units) by Type (2024-2034)
Table 52. Global Hip Osteoarthritis Pain Medicine Sales Market Share by Type (2018-2023)
Table 53. Global Hip Osteoarthritis Pain Medicine Sales Market Share by Type (2024-2034)
Table 54. Global Hip Osteoarthritis Pain Medicine Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Hip Osteoarthritis Pain Medicine Revenue (US$ Million) by Type (2024-2034)
Table 56. Global Hip Osteoarthritis Pain Medicine Revenue Market Share by Type (2018-2023)
Table 57. Global Hip Osteoarthritis Pain Medicine Revenue Market Share by Type (2024-2034)
Table 58. Global Hip Osteoarthritis Pain Medicine Price (USD/Unit) by Type (2018-2023)
Table 59. Global Hip Osteoarthritis Pain Medicine Price (USD/Unit) by Type (2024-2034)
Table 60. Global Hip Osteoarthritis Pain Medicine Sales (K Units) by Application (2018-2023)
Table 61. Global Hip Osteoarthritis Pain Medicine Sales (K Units) by Application (2024-2034)
Table 62. Global Hip Osteoarthritis Pain Medicine Sales Market Share by Application (2018-2023)
Table 63. Global Hip Osteoarthritis Pain Medicine Sales Market Share by Application (2024-2034)
Table 64. Global Hip Osteoarthritis Pain Medicine Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Hip Osteoarthritis Pain Medicine Revenue (US$ Million) by Application (2024-2034)
Table 66. Global Hip Osteoarthritis Pain Medicine Revenue Market Share by Application (2018-2023)
Table 67. Global Hip Osteoarthritis Pain Medicine Revenue Market Share by Application (2024-2034)
Table 68. Global Hip Osteoarthritis Pain Medicine Price (USD/Unit) by Application (2018-2023)
Table 69. Global Hip Osteoarthritis Pain Medicine Price (USD/Unit) by Application (2024-2034)
Table 70. Pfizer Corporation Information
Table 71. Pfizer Description and Business Overview
Table 72. Pfizer Hip Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 73. Pfizer Hip Osteoarthritis Pain Medicine Product
Table 74. Pfizer Recent Developments/Updates
Table 75. Johnson and Johnson Corporation Information
Table 76. Johnson and Johnson Description and Business Overview
Table 77. Johnson and Johnson Hip Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 78. Johnson and Johnson Hip Osteoarthritis Pain Medicine Product
Table 79. Johnson and Johnson Recent Developments/Updates
Table 80. GlaxoSmithKline Corporation Information
Table 81. GlaxoSmithKline Description and Business Overview
Table 82. GlaxoSmithKline Hip Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 83. GlaxoSmithKline Hip Osteoarthritis Pain Medicine Product
Table 84. GlaxoSmithKline Recent Developments/Updates
Table 85. Bayer Corporation Information
Table 86. Bayer Description and Business Overview
Table 87. Bayer Hip Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 88. Bayer Hip Osteoarthritis Pain Medicine Product
Table 89. Bayer Recent Developments/Updates
Table 90. Eli Lilly Corporation Information
Table 91. Eli Lilly Description and Business Overview
Table 92. Eli Lilly Hip Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 93. Eli Lilly Hip Osteoarthritis Pain Medicine Product
Table 94. Eli Lilly Recent Developments/Updates
Table 95. Novartis Corporation Information
Table 96. Novartis Description and Business Overview
Table 97. Novartis Hip Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 98. Novartis Hip Osteoarthritis Pain Medicine Product
Table 99. Novartis Recent Developments/Updates
Table 100. Sanofi Corporation Information
Table 101. Sanofi Description and Business Overview
Table 102. Sanofi Hip Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 103. Sanofi Hip Osteoarthritis Pain Medicine Product
Table 104. Sanofi Recent Developments/Updates
Table 105. Horizon Pharma Corporation Information
Table 106. Horizon Pharma Description and Business Overview
Table 107. Horizon Pharma Hip Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 108. Horizon Pharma Hip Osteoarthritis Pain Medicine Product
Table 109. Horizon Pharma Recent Developments/Updates
Table 110. Abbott Corporation Information
Table 111. Abbott Description and Business Overview
Table 112. Abbott Hip Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 113. Abbott Hip Osteoarthritis Pain Medicine Product
Table 114. Abbott Recent Developments/Updates
Table 115. Mylan Corporation Information
Table 116. Mylan Description and Business Overview
Table 117. Mylan Hip Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 118. Mylan Hip Osteoarthritis Pain Medicine Product
Table 119. Mylan Recent Developments/Updates
Table 120. Daiichi Sankyo Corporation Information
Table 121. Daiichi Sankyo Description and Business Overview
Table 122. Daiichi Sankyo Hip Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 123. Daiichi Sankyo Hip Osteoarthritis Pain Medicine Product
Table 124. Daiichi Sankyo Recent Developments/Updates
Table 125. TEVA Corporation Information
Table 126. TEVA Description and Business Overview
Table 127. TEVA Hip Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 128. TEVA Hip Osteoarthritis Pain Medicine Product
Table 129. TEVA Recent Developments/Updates
Table 130. Almatica Pharma Corporation Information
Table 131. Almatica Pharma Description and Business Overview
Table 132. Almatica Pharma Hip Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 133. Almatica Pharma Hip Osteoarthritis Pain Medicine Product
Table 134. Almatica Pharma Recent Developments/Updates
Table 135. Astellas Pharma Corporation Information
Table 136. Astellas Pharma Description and Business Overview
Table 137. Astellas Pharma Hip Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 138. Astellas Pharma Hip Osteoarthritis Pain Medicine Product
Table 139. Astellas Pharma Recent Developments/Updates
Table 140. Tide Pharmaceutical Corporation Information
Table 141. Tide Pharmaceutical Description and Business Overview
Table 142. Tide Pharmaceutical Hip Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 143. Tide Pharmaceutical Hip Osteoarthritis Pain Medicine Product
Table 144. Tide Pharmaceutical Recent Developments/Updates
Table 145. Iroko Pharmaceuticals Corporation Information
Table 146. Iroko Pharmaceuticals Description and Business Overview
Table 147. Iroko Pharmaceuticals Hip Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 148. Iroko Pharmaceuticals Hip Osteoarthritis Pain Medicine Product
Table 149. Iroko Pharmaceuticals Recent Developments/Updates
Table 150. Hengrui Pharmaceutical Corporation Information
Table 151. Hengrui Pharmaceutical Description and Business Overview
Table 152. Hengrui Pharmaceutical Hip Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 153. Hengrui Pharmaceutical Hip Osteoarthritis Pain Medicine Product
Table 154. Hengrui Pharmaceutical Recent Developments/Updates
Table 155. Abiogen Pharma Corporation Information
Table 156. Abiogen Pharma Description and Business Overview
Table 157. Abiogen Pharma Hip Osteoarthritis Pain Medicine Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 158. Abiogen Pharma Hip Osteoarthritis Pain Medicine Product
Table 159. Abiogen Pharma Recent Developments/Updates
Table 160. Key Raw Materials Lists
Table 161. Raw Materials Key Suppliers Lists
Table 162. Hip Osteoarthritis Pain Medicine Distributors List
Table 163. Hip Osteoarthritis Pain Medicine Customers List
Table 164. Hip Osteoarthritis Pain Medicine Market Trends
Table 165. Hip Osteoarthritis Pain Medicine Market Drivers
Table 166. Hip Osteoarthritis Pain Medicine Market Challenges
Table 167. Hip Osteoarthritis Pain Medicine Market Restraints
Table 168. Research Programs/Design for This Report
Table 169. Key Data Information from Secondary Sources
Table 170. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Hip Osteoarthritis Pain Medicine
Figure 2. Global Hip Osteoarthritis Pain Medicine Market Value Comparison by Type (2024-2034) & (US$ Million)
Figure 3. Global Hip Osteoarthritis Pain Medicine Market Share by Type in 2024 & 2034
Figure 4. Oral Product Picture
Figure 5. Injection Product Picture
Figure 6. External Product Picture
Figure 7. Global Hip Osteoarthritis Pain Medicine Market Value Comparison by Application (2024-2034) & (US$ Million)
Figure 8. Global Hip Osteoarthritis Pain Medicine Market Share by Application in 2024 & 2034
Figure 9. Medical Care
Figure 10. Personal Care
Figure 11. Global Hip Osteoarthritis Pain Medicine Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 12. Global Hip Osteoarthritis Pain Medicine Market Size (2018-2034) & (US$ Million)
Figure 13. Global Hip Osteoarthritis Pain Medicine Sales (2018-2034) & (K Units)
Figure 14. Global Hip Osteoarthritis Pain Medicine Average Price (USD/Unit) & (2018-2034)
Figure 15. Hip Osteoarthritis Pain Medicine Report Years Considered
Figure 16. Hip Osteoarthritis Pain Medicine Sales Share by Manufacturers in 2024
Figure 17. Global Hip Osteoarthritis Pain Medicine Revenue Share by Manufacturers in 2024
Figure 18. The Global 5 and 10 Largest Hip Osteoarthritis Pain Medicine Players: Market Share by Revenue in 2024
Figure 19. Hip Osteoarthritis Pain Medicine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2024
Figure 20. Global Hip Osteoarthritis Pain Medicine Market Size by Region (US$ Million): 2018 VS 2024 VS 2034
Figure 21. North America Hip Osteoarthritis Pain Medicine Sales Market Share by Country (2018-2034)
Figure 22. North America Hip Osteoarthritis Pain Medicine Revenue Market Share by Country (2018-2034)
Figure 23. U.S. Hip Osteoarthritis Pain Medicine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 24. Canada Hip Osteoarthritis Pain Medicine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 25. Europe Hip Osteoarthritis Pain Medicine Sales Market Share by Country (2018-2034)
Figure 26. Europe Hip Osteoarthritis Pain Medicine Revenue Market Share by Country (2018-2034)
Figure 27. Germany Hip Osteoarthritis Pain Medicine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 28. France Hip Osteoarthritis Pain Medicine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 29. U.K. Hip Osteoarthritis Pain Medicine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 30. Italy Hip Osteoarthritis Pain Medicine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 31. Russia Hip Osteoarthritis Pain Medicine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 32. Asia Pacific Hip Osteoarthritis Pain Medicine Sales Market Share by Region (2018-2034)
Figure 33. Asia Pacific Hip Osteoarthritis Pain Medicine Revenue Market Share by Region (2018-2034)
Figure 34. China Hip Osteoarthritis Pain Medicine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 35. Japan Hip Osteoarthritis Pain Medicine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 36. South Korea Hip Osteoarthritis Pain Medicine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 37. India Hip Osteoarthritis Pain Medicine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 38. Australia Hip Osteoarthritis Pain Medicine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 39. Taiwan Hip Osteoarthritis Pain Medicine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 40. Indonesia Hip Osteoarthritis Pain Medicine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 41. Thailand Hip Osteoarthritis Pain Medicine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 42. Malaysia Hip Osteoarthritis Pain Medicine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 43. Philippines Hip Osteoarthritis Pain Medicine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 44. Latin America Hip Osteoarthritis Pain Medicine Sales Market Share by Country (2018-2034)
Figure 45. Latin America Hip Osteoarthritis Pain Medicine Revenue Market Share by Country (2018-2034)
Figure 46. Mexico Hip Osteoarthritis Pain Medicine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 47. Brazil Hip Osteoarthritis Pain Medicine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 48. Argentina Hip Osteoarthritis Pain Medicine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 49. Middle East & Africa Hip Osteoarthritis Pain Medicine Sales Market Share by Country (2018-2034)
Figure 50. Middle East & Africa Hip Osteoarthritis Pain Medicine Revenue Market Share by Country (2018-2034)
Figure 51. Turkey Hip Osteoarthritis Pain Medicine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 52. Saudi Arabia Hip Osteoarthritis Pain Medicine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 53. UAE Hip Osteoarthritis Pain Medicine Revenue Growth Rate (2018-2034) & (US$ Million)
Figure 54. Global Sales Market Share of Hip Osteoarthritis Pain Medicine by Type (2018-2034)
Figure 55. Global Revenue Market Share of Hip Osteoarthritis Pain Medicine by Type (2018-2034)
Figure 56. Global Hip Osteoarthritis Pain Medicine Price (USD/Unit) by Type (2018-2034)
Figure 57. Global Sales Market Share of Hip Osteoarthritis Pain Medicine by Application (2018-2034)
Figure 58. Global Revenue Market Share of Hip Osteoarthritis Pain Medicine by Application (2018-2034)
Figure 59. Global Hip Osteoarthritis Pain Medicine Price (USD/Unit) by Application (2018-2034)
Figure 60. Hip Osteoarthritis Pain Medicine Value Chain
Figure 61. Hip Osteoarthritis Pain Medicine Production Process
Figure 62. Channels of Distribution (Direct Vs Distribution)
Figure 63. Distributors Profiles
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed